Page last updated: 2024-10-22

amantadine and Amentia

amantadine has been researched along with Amentia in 18 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Research Excerpts

ExcerptRelevanceReference
"The objective of this study is to compare the occurrence of dementia among Parkinson's disease (PD) patients treated with amantadine (AM group) with those never exposed to it (NoAM group)."7.73Association between amantadine and the onset of dementia in Parkinson's disease. ( Bonuccelli, U; Ceravolo, R; Inzelberg, R; Klein, C; Logi, C; Miniowich, A; Rabey, JM; Rossi, C; Schechtman, E; Strugatsky, R, 2006)
"Thalamic dementia is an uncommon type of stroke that presents with disorientation, behavioral changes, and impairment of executive functions, with relative preservation of motor functions."5.62Thalamic Dementia in Acute Inpatient Rehabilitation-Role for Amantadine? ( Brentlinger, G; Ghebrendrias, Y; Han, J; Kim, K; Mohan, A; Yeh, BY, 2021)
"Nineteen patients with senile brain disease (including 2 with parkinsonian symptoms) were treated with amantadine in an oral dosage of 200--300 mg daily."5.26Amantadine in senile dementia: electroencephalographic and clinical effects. ( Boillat, J; Cole, M; Dastoor, DP; Klingner, A; Müller, HF, 1979)
" Drugs used to treat PD, such as levodopa, offer symptomatic relief but often have neuropsychiatric adverse effects, most prominently psychosis and delirium."4.79Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. ( Camicioli, R; Ganzini, L; Young, BK, 1997)
"The objective of this study is to compare the occurrence of dementia among Parkinson's disease (PD) patients treated with amantadine (AM group) with those never exposed to it (NoAM group)."3.73Association between amantadine and the onset of dementia in Parkinson's disease. ( Bonuccelli, U; Ceravolo, R; Inzelberg, R; Klein, C; Logi, C; Miniowich, A; Rabey, JM; Rossi, C; Schechtman, E; Strugatsky, R, 2006)
"Memantine was investigated in a phase II double-blind trial on 30 elderly patients by comparison with a placebo with the aid of several psychometric tests."2.66Treatment of impaired cerebral function in psychogeriatric patients with memantine--results of a phase II double-blind study. ( Ambrozi, L; Danielczyk, W, 1988)
"Thalamic dementia is an uncommon type of stroke that presents with disorientation, behavioral changes, and impairment of executive functions, with relative preservation of motor functions."1.62Thalamic Dementia in Acute Inpatient Rehabilitation-Role for Amantadine? ( Brentlinger, G; Ghebrendrias, Y; Han, J; Kim, K; Mohan, A; Yeh, BY, 2021)
"Nineteen patients with senile brain disease (including 2 with parkinsonian symptoms) were treated with amantadine in an oral dosage of 200--300 mg daily."1.26Amantadine in senile dementia: electroencephalographic and clinical effects. ( Boillat, J; Cole, M; Dastoor, DP; Klingner, A; Müller, HF, 1979)
" In the antipsychotic classification, special attention is given to side effects (extrapyramidal motor signs, tardive dyskinesias, akathisis) and to dosage for the elderly."1.25Observations on the psychopharmacology of the aged. ( Eisdorfer, C, 1975)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-199010 (55.56)18.7374
1990's3 (16.67)18.2507
2000's2 (11.11)29.6817
2010's1 (5.56)24.3611
2020's2 (11.11)2.80

Authors

AuthorsStudies
Kim, K1
Mohan, A1
Yeh, BY1
Ghebrendrias, Y1
Brentlinger, G1
Han, J1
Chang, MC1
Wang, F1
Feng, TY1
Yang, S1
Preter, M1
Zhou, JN1
Wang, XP1
Swarztrauber, K1
Koudelka, C1
Brodsky, MA1
Inzelberg, R1
Bonuccelli, U1
Schechtman, E1
Miniowich, A1
Strugatsky, R1
Ceravolo, R1
Logi, C1
Rossi, C1
Klein, C1
Rabey, JM1
Allen, RM1
Gradner, W1
Schnaberth, G1
Auff, E1
Young, BK1
Camicioli, R1
Ganzini, L1
Eisdorfer, C1
Müller, HF1
Dastoor, DP1
Klingner, A1
Cole, M1
Boillat, J1
Semlitsch, HV1
Anderer, P1
Saletu, B1
Hermesh, H1
Sirota, P1
Eviatar, J1
Sawada, H1
Akiguchi, I1
Kimura, T1
Fukuyama, H1
Kameyama, M1
Harvey, NS1
Otomo, E1
Ambrozi, L1
Danielczyk, W1
Powell, HC1
London, GW1
Lampert, PW1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of a Modified Mindfulness-based Cognitive Therapy for Family Caregivers of People With Dementia in Stress Reduction: A Randomized Controlled Trial[NCT03354819]113 participants (Actual)Interventional2017-12-23Completed
Feru-guard (Ferulic Acid and Angelica Archangelica Extract) for Behavioral Symptoms in Dementia[NCT03451760]Phase 270 participants (Anticipated)Interventional2018-09-30Not yet recruiting
An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist With Neurotrophic Properties in Major Depression[NCT00040261]Phase 3112 participants Interventional2002-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for amantadine and Amentia

ArticleYear
Drug Therapy for Behavioral and Psychological Symptoms of Dementia.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Amantadine; Antidepressive Agents; Antipsychotic Agents; Behavioral Symptoms; Cholinesterase Inhibit

2016
Drug Therapy for Behavioral and Psychological Symptoms of Dementia.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Amantadine; Antidepressive Agents; Antipsychotic Agents; Behavioral Symptoms; Cholinesterase Inhibit

2016
Drug Therapy for Behavioral and Psychological Symptoms of Dementia.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Amantadine; Antidepressive Agents; Antipsychotic Agents; Behavioral Symptoms; Cholinesterase Inhibit

2016
Drug Therapy for Behavioral and Psychological Symptoms of Dementia.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Amantadine; Antidepressive Agents; Antipsychotic Agents; Behavioral Symptoms; Cholinesterase Inhibit

2016
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
    Drugs & aging, 1997, Volume: 10, Issue:5

    Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic

1997
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
    Psychosomatics, 1986, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug I

1986

Trials

2 trials available for amantadine and Amentia

ArticleYear
Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4

    Topics: Aged; Amantadine; Brain; Brain Mapping; Cognition; Dementia; Double-Blind Method; Electrooculography

1992
Treatment of impaired cerebral function in psychogeriatric patients with memantine--results of a phase II double-blind study.
    Pharmacopsychiatry, 1988, Volume: 21, Issue:3

    Topics: Aged; Amantadine; Dementia; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Memantine; N

1988

Other Studies

13 other studies available for amantadine and Amentia

ArticleYear
Thalamic Dementia in Acute Inpatient Rehabilitation-Role for Amantadine?
    American journal of physical medicine & rehabilitation, 2021, 01-01, Volume: 100, Issue:1

    Topics: Amantadine; Cerebral Infarction; Dementia; Dopamine Agents; Humans; Male; Middle Aged; Thalamic Nucl

2021
Comments on "Thalamic Dementia in Acute Inpatient Rehabilitation-Role for Amantadine? A Case Report".
    American journal of physical medicine & rehabilitation, 2021, 09-01, Volume: 100, Issue:9

    Topics: Amantadine; Dementia; Humans; Inpatients; Thalamus

2021
Initial pharmacotherapy in a population of veterans with Parkinson disease.
    Neurology, 2006, May-09, Volume: 66, Issue:9

    Topics: Age Factors; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Cholinergic Antagonists; Dat

2006
Association between amantadine and the onset of dementia in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9

    Topics: Aged; Amantadine; Antiparkinson Agents; Comorbidity; Dementia; Female; Humans; Male; Mental Status S

2006
Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Biological psychiatry, 1982, Volume: 17, Issue:6

    Topics: Adult; Aged; Amantadine; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Drug Ther

1982
[The Steel Richardson Olszewski-syndrome. A report on 3 further cases (author's transl)].
    Fortschritte der Neurologie-Psychiatrie, 1981, Volume: 49, Issue:6

    Topics: Amantadine; Biperiden; Bulbar Palsy, Progressive; Dementia; Dysarthria; Humans; Male; Middle Aged; O

1981
[Dementia--Parkinson disease: role of antiglutamatergic drugs. Symposium: 4 April, Hamburg].
    Fortschritte der Neurologie-Psychiatrie, 1998, Volume: 66, Issue:6 Suppl De

    Topics: Amantadine; Antipsychotic Agents; Dementia; Humans; Levodopa; Movement Disorders; Parkinson Disease;

1998
Observations on the psychopharmacology of the aged.
    Journal of the American Geriatrics Society, 1975, Volume: 23, Issue:2

    Topics: Aged; Amantadine; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Butyrophenone

1975
Amantadine in senile dementia: electroencephalographic and clinical effects.
    Journal of the American Geriatrics Society, 1979, Volume: 27, Issue:1

    Topics: Administration, Oral; Aged; Amantadine; Anxiety; Dementia; Depression; Electroencephalography; Femal

1979
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
    Biological psychiatry, 1989, Apr-01, Volume: 25, Issue:7

    Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malign

1989
[A case of venous dural sinus thrombosis presenting dementia syndrome. An autopsy case].
    Rinsho shinkeigaku = Clinical neurology, 1989, Volume: 29, Issue:3

    Topics: Amantadine; Brain; Calcinosis; Dementia; Humans; Male; Middle Aged; Sinus Thrombosis, Intracranial

1989
[Drug therapy of Alzheimer's disease. General concepts on nootropic drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1988, Volume: 46, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Aminoacridines; Dementia; gamma-Aminobutyric

1988
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.
    Journal of neuropathology and experimental neurology, 1974, Volume: 33, Issue:1

    Topics: Aged; Amantadine; Brain; Brain Diseases; Bulbar Palsy, Progressive; Dementia; Dihydroxyphenylalanine

1974